Ciprofloxacin in the elimination of enteric Salmonella carriage stage.
According to the present experience, ciprofloxacin seems to be a new promising drug for the treatment of enteric salmonella carriage stage. This paper reviews results with ciprofloxacin and older drugs. While the cure rates in previous studies were about 70%, it was at least 90% with ciprofloxacin although the treatment time was shorter and the rate of side effects was lower. However the final place of ciprofloxacin on this indication needs to be investigated further.
Lähdevirta
J
J
Aurora Hospital, Helsinki, Finland.
D002353:Carrier State / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000382:microbiology; D012480:Salmonella Infections / Q000188:drug therapy*
D002939:Ciprofloxacin